[Pharmacodynamic aspects of digitalis therapy].
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D003404:Creatinine / Q000378:metabolism; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use*; D004573:Electrolytes / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000187:drug effects
D004071:Digitalis Glycosides; D004573:Electrolytes; D000255:Adenosine Triphosphate; D003404:Creatinine; D000251:Adenosine Triphosphatases
Aspetti farmacodinamici della terapia digitalica